French multicenter study to evaluate ctDNA after liver metastasis surgery Skip to content The CRC Digest French multicenter study to evaluate ctDNA after liver metastasis surgery The CLIMES PRODIGE 77 study will enroll 232 patients undergoing curative-intent liver metastasis resection to evaluate circulating tumor DNA as a biomarker for detecting minimal residual disease and predicting prognosis. (BMJ Open) This content
CRC Research Finding Skip to content The CRC Digest ▸ Multi-omics deep learning model predicts anti-EGFR therapy response in liver metastases A multi-center study developed a deep learning framework integrating multi-omics data to predict which RAS wild-type colorectal cancer liver metastases patients will benefit from cetuximab therapy, addressing primary resistance challenges. (Curr Cancer Drug
Prognostic Factors in Young Patients with Liver Metastases Skip to content The CRC Digest Prognostic Factors in Young Patients with Liver Metastases A SEER database study of 2,222 patients with colorectal liver metastases compared disease-specific survival in those under 45 versus 45 and older who underwent colon and liver resection from 2010 to 2021. (J Surg Oncol)